Cover Image
市場調查報告書

Beijing Labsolutions Pharmaceuticals Co., Ltd.:產品平台分析

Beijing Labsolutions Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 305691
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
Beijing Labsolutions Pharmaceuticals Co., Ltd.:產品平台分析 Beijing Labsolutions Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014
出版日期: 2014年06月10日 內容資訊: 英文 25 Pages
簡介

本報告提供Beijing Labsolutions Pharmaceuticals Co., Ltd.的治療藥開發平台現狀及各開發階段的比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,彙整最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

Beijing Labsolutions Pharmaceuticals Co., Ltd.的基本資料

Beijing Labsolutions Pharmaceuticals Co., Ltd.概要

  • 主要資訊
  • 企業資料

Beijing Labsolutions Pharmaceuticals Co., Ltd.:R&D概要

  • 主要的治療範圍

Beijing Labsolutions Pharmaceuticals Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Beijing Labsolutions Pharmaceuticals Co., Ltd.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Beijing Labsolutions Pharmaceuticals Co., Ltd.:藥物簡介

  • BL-001
  • BL-003
  • BL-0007
  • BL-006
  • BL-008
  • BL-009
  • BL-011
  • BL-012

Beijing Labsolutions Pharmaceuticals Co., Ltd.:開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

Beijing Labsolutions Pharmaceuticals Co., Ltd.:總公司和子公司的所在地

附錄

目錄
Product Code: GMDHC04959CDB

Global Markets Direct's, 'Beijing Labsolutions Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Beijing Labsolutions Pharmaceuticals Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Beijing Labsolutions Pharmaceuticals Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Beijing Labsolutions Pharmaceuticals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Beijing Labsolutions Pharmaceuticals Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Beijing Labsolutions Pharmaceuticals Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Beijing Labsolutions Pharmaceuticals Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Beijing Labsolutions Pharmaceuticals Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Beijing Labsolutions Pharmaceuticals Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Beijing Labsolutions Pharmaceuticals Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Beijing Labsolutions Pharmaceuticals Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Beijing Labsolutions Pharmaceuticals Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. Snapshot
    • Beijing Labsolutions Pharmaceuticals Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products Glance
    • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Drug Profiles
    • BL-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-003
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-0007
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-006
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-008
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-009
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-011
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BL-012
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Analysis
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products by Target
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Beijing Labsolutions Pharmaceuticals Co., Ltd., Key Information
  • Beijing Labsolutions Pharmaceuticals Co., Ltd., Key Facts
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Indication, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Preclinical, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Discovery, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Target, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2014

List of Figures

  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Indication, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Target, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
  • Beijing Labsolutions Pharmaceuticals Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top